2018
DOI: 10.1002/acn3.598
|View full text |Cite
|
Sign up to set email alerts
|

FARS2 mutations presenting with pure spastic paraplegia and lesions of the dentate nuclei

Abstract: Mutations in FARS2, the gene encoding the mitochondrial phenylalanine‐tRNA synthetase (mtPheRS), have been linked to a range of phenotypes including epileptic encephalopathy, developmental delay, and motor dysfunction. We report a 9‐year‐old boy with novel compound heterozygous variants of FARS2, presenting with a pure spastic paraplegia syndrome associated with bilateral signal abnormalities in the dentate nuclei. Exome sequencing identified a paternal nonsense variant (Q216X) lacking the catalytic core and a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 15 publications
1
4
0
Order By: Relevance
“…(1 case: leukodystrophy) [20] and NARS2 (1 case: global brain atrophy) [21,22]. Our study also points to the involvement of the dentate nuclei in pathogenic FARS2 variants (3 of the 4 cases) [23][24][25]. Finally, the apparent absence of brain MRI anomalies in 5 (3 IARS2, 1 YARS2, and 1 FARS2) of the 25 patients suggests that normal brain MRI images do not exclude the diagnosis of ARS2 mutations in mitochondrial diseases.…”
Section: New Findingssupporting
confidence: 53%
“…(1 case: leukodystrophy) [20] and NARS2 (1 case: global brain atrophy) [21,22]. Our study also points to the involvement of the dentate nuclei in pathogenic FARS2 variants (3 of the 4 cases) [23][24][25]. Finally, the apparent absence of brain MRI anomalies in 5 (3 IARS2, 1 YARS2, and 1 FARS2) of the 25 patients suggests that normal brain MRI images do not exclude the diagnosis of ARS2 mutations in mitochondrial diseases.…”
Section: New Findingssupporting
confidence: 53%
“…One patient had an originally reported VUS in the PNPLA6 gene reclassified as benign and a previously unreported VUS reported in the TBK1 gene due to a more consistent phenotype. Last, one patient had originally reported VUS in the ZFYVE26 gene reclassified as benign and a previously unreported pathogenic variant reported in the FARS2 gene (Sahai et al, 2018) due to a more consistent phenotype along with the identification of the second pathogenic variant through our CNV analysis (Table 4). As described above, the CNV analysis of 15 families from this original cohort (20%, 15/76) identified one (7%, 1/15) pathogenic/likely pathogenic variant.…”
Section: Resultsmentioning
confidence: 95%
“…[ 8 ] 7 NA NA F Seizure, 2 months Normal Globally delayed development, mild facial dysmorphism, an elevated lactate level, truncal hypotonia with brisk extremity reflexes throughout, and an intermittent intention tremor Alive at 5 years of age p.R419C/a 116 kb microdeletion (het) 8 NA NA M Seizures, only within 6 weeks after birth Two small foci of T2/FLAIR hyperintensity involving the periventricular white matter and deep white matter of the right posterior frontal lobe Delayed development, cerebral palsy, metabolic acidosis, truncal hypotonia, dysarthric speech, and a mild intention tremor Alive at 13 years of age p.R419C/a 116 kb microdeletion (het) Almannai et al [ 6 ] 9 North American No F No Brain atrophy Developmental delay, spastic paraplegia Alive at 20 years of age p.H159P/p.R419C (het) 10 North American No F No NA Developmental delay, spastic paraplegia Alive at 17 years of age p.H159P/p.R419C (het) Sahai et al . [ 21 ] 11 Northern European and Ashkenazi Jewish No M No Abnormal signal hyperintensities in the bilateral dentate nuclei Spasticity in lower extremities Alive at 9 years of age p.Q216X/p.P136H (het) Meszarosova et al . [ 22 ...…”
Section: Discussionmentioning
confidence: 99%